Searched for
DRUG DISCOVERY SERVICES
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- India’s quantum opportunity: Turning scale into strategic advantageIndia has a structural advantage in quantum computing. Its size inherently creates challenging optimisation issues, offering a practical te...
- Intel spinout Articul8 eyes $50 million for India heritage AI ventureArticul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...
- Scientists discovered a forgotten 'yellow brick road' at the bottom of the oceanScientists aboard the Nautilus exploration vessel were astonished to discover a remarkably paved 'road' on the ocean floor near Hawaii. Thi...
- IT still a question mark; 6 sectors where Envision Capital's Nilesh Shah is actually putting moneyNilesh Shah, MD and CEO of Envision Capital, is buying through market volatility but steering clear of IT, questioning the validity of curr...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Fractal bets big on enterprise AI despite TMT weakness dragging revenue growthAnalytics firm Fractal sees robust enterprise AI growth, with banking and life sciences booming at 40% and 80% respectively. Despite a dip ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- ET Most Innovative AI Product Awards 2026: Honouring the innovations powering India's next economyThe ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...
- Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- India's drug discovery and development: Small research firms aim to change face of cancer therapyIndia is not known for developing drugs, let along cancer drugs, but a few small and niche firms are trying exactly that, reports ET.
- Jubilant Chemsys, IDRI extend research for TB drug discoveryJubilant Chemsys, today announced an extension of collaborative partnership with Infectious Disease Research Institute (IDRI) for TB drug d...
- Jubilant, IDRI extend research for TB drug discoveryJubilant Chemsys, under the terms of agreement, so far had been offering philanthropic support and expertise in synthesis of NCEs to suppor...
- Jubilant Biosys expands drug discovery alliance with JanssenJubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...
- GVK Biosciences and CRELUX set up drug discovery platformGVK Biosciences and CRELUX have set-up a highly robust fragment-based drug discovery platform proven to deliver rapidly, viable lead molecu...
- Jubilant Organosys in drug discovery partnership with BioLeapJubilant Organosys has entered into a drug discovery partnership with US-based BioLeap, LLC.
Load More
